omega-n-methylarginine has been researched along with tezosentan in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (tezosentan) | Trials (tezosentan) | Recent Studies (post-2010) (tezosentan) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 157 | 29 | 33 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | tezosentan (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Homo sapiens (human) | 0.021 | |
| Endothelin-1 receptor | Homo sapiens (human) | 0.0205 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beresewicz, A; Boemke, W; Duda, M; Kurzelewski, M; Stanley, WC | 1 |
1 other study(ies) available for omega-n-methylarginine and tezosentan
| Article | Year |
|---|---|
Nitric oxide synthase inhibition and elevated endothelin increase oxygen consumption but do not affect glucose and palmitate oxidation in the isolated rat heart.
Topics: Animals; Coronary Circulation; Diastole; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Glucose; Heart Rate; Heart Ventricles; Lactic Acid; Male; Myocardium; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen Consumption; Palmitates; Pyridines; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Tetrazoles; Tritium; Ventricular Function; Water | 2004 |